Takeda Pharmaceuticals’ Dexilant SoluTab delayed-release orally disintegrating tablets received FDA approval. 1. The tablets are a new formulation of dexlansoprazole that can be taken by allowing the ...
TWi Pharmaceuticals, Inc. ("TWi") today announced that it has entered into a Settlement Agreement with Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals U.S.A., Inc., Takeda ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results